Vascular access complications in daily dialysis: A systematic review of the literature

Minerva Urologica e Nefrologica

Volumn 57, Issue 3, 2005, Pages 151-163

  Shurraw, S ^a   Zimmerman, D ^a,b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Kidney Research Centre   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Arterio venous fistula; Arterio venous graft; Central venous catheter; Daily dialysis; Hemodialysis; Nocturnal dialysis; Quotidian dialysis; Vascular access

Indexed keywords

ANEMIA; CANNULATION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; COHORT ANALYSIS; DIALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HUMAN; HYPERPHOSPHATEMIA; HYPERTENSION; INTERMETHOD COMPARISON; KIDNEY DISEASE; KIDNEY FAILURE; META ANALYSIS; NUTRITIONAL ASSESSMENT; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VASCULAR ACCESS;

ARTERIOVENOUS SHUNT, SURGICAL; CANADA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; EVIDENCE-BASED MEDICINE; HUMANS; INFECTION; INFECTION CONTROL; KIDNEY FAILURE, CHRONIC; QUALITY OF LIFE; RENAL DIALYSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33745360253     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. USRDS: the United States Renal Data System. Am J Kidney Dis 2003;42:1-230.
2. Evans RW, Manninen DL, Garrison LP Jr, Hart LG, Blagg CR, Gutman RA et al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985;312:553-9.
3. Pierratos A, Ouwendyk M, Francoeur R, Vas S, Raj DS, Ecclestone AM et al. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol 1998;9:859-68.
4. Raj DS, Ouwendyk M, Francoeur R, Pierratos A. beta(2)-microglobulin kinetics in nocturnal haemodialysis. Nephrol Dial Transplant 2000;15:58-64.
5. Mucsi I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 1998;53:1399-404.
6. Pierratos A. Nocturnal home haemodialysis: an update on a 5-year experience. Nephrol Dial Transplant 1999;14:2835-40.
7. Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 2002;61:2235-9.
8. Chan C, Floras JS, Miller JA, Pierratos A. Improvement in ejection fraction by nocturnal haemodialysis in endstage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 2002;17:1518-21.
9. Bugeja AL, Chan CT. Improvement in lipid profile by nocturnal hemodialysis in patients with end-stage renal disease. Asaio J 2004;50:328-31.
10. Ting GO, Kjellstrand C, Freitas T, Carrie BJ, Zarghamee S. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis 2003;42:1020-35.
11. Mohr PE, Neumann PJ, Franco SJ, Marainen J, Lockridge R, Ting G. The case for daily dialysis: its impact on costs and quality of life. Am J Kidney Dis 2001;37:777-89.
12. McFarlane PA, Pierratos A, Redelmeier DA. Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int 2002;62:2216-22.
13. Kroeker A, Clark WF, Heidenheim AP, Kuenzig L, Leitch R, Meyette M et al. An operating cost comparison between conventional and home quotidian hemodialysis. Am J Kidney Dis 2003;42:49-55.
14. Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JA. Hemodialysis vascular access morbidity in the United States. Kidney Int 1993;43:1091-6.
15. Munda R, First MR, Alexander JW, Linnemann CC Jr, Fidler JP, Kittur D. Polytetrafluoroethylene graft survival in hemodialysis. JAMA 1983;249:219-22.
16. Palder SB, Kirkman RL, Whittemore AD, Hakim RM, Lazarus JM, Tilney NL. Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg 1985;202:235-9.
17. Young EW, Dykstra DM, Goodkin DA, Mapes DL, Wolfe RA, Held PJ. Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2002;61:2266-71.
18. Lund GB, Trerotola SO, Scheel PF Jr, Savader SJ, Mitchell SE, Venbrux AC et al. Outcome of tunneled hemodialysis catheters placed by radiologists. Radiology 1996;198:467-72.
19. Suhocki PV, Conlon PJ Jr, Knelson MH, Harland R, Schwab SJ. Silastic cuffed catheters for hemodialysis vascular access: thrombolytic and mechanical correction of malfunction. Am J Kidney Dis 1996;28:379-86.
20. Cheesbrough JS, Finch RG, Burden RP. A prospective study of the mechanisms of infection associated with hemodialysis catheters. J Infect Dis 1986;154:579-89.
21. Dobkin JF, Miller MH, Steigbigel NH. Septicemia in patients on chronic hemodialysis. Ann Intern Med 1978;88:28-33.
22. Woods JD, Port FK, Orzol S, Young E, Wolfe RA, Held PJ. Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int 1999;55:2467-76.
23. Pierratos A, Goluboff D, Ouwendyk M. Vascular access for nocturnal hemodialysis. J Am Soc Nephrol 1999;10:215A.
24. Quintaliani G, Buoncristiani U, Fagugli R, Kuluiranu H, Ciao G, Rondini L et al. Survival of vascular access during daily and three times a week hemodialysis. Clin Nephrol 2000;53:372-7.
25. Lindsay RM, Leitch R, Heidenheim AP, Kortas C. The London Daily/Nocturnal Hemodialysis Study-study design, morbidity, and mortality results. Am J Kidney Dis 2003;42:5-12.
26. Piccoli GB, Bermond F, Mezza E, Burdese M, Fop F, Mangiarotti G et al. Vascular access survival and morbidity on daily dialysis: a comparative analysis of home and limited care haemodialysis. Nephrol Dial Transplant 2004;19:2084-94.
27. Galland R, Traeger J, Arkouche W, Delawari E. Arteriovenous fistula and daily hemodialysis. J Am Soc Nephrol 2004;15:804-5A.
28. Woods JD, Port FK. The impact of vascular access for haemodialysis on patient morbidity and mortality. Nephrol Dial Transplant 1997;12:657-9.
29. Mastrangelo F, Alfonso L, Napoli M, DeBlasi V, Russo F, Patruno P. Dialysis with increased frequency of sessions (Lecce dialysis). Nephrol Dial Transplant 1998;13 Suppl 6:139-47.
30. Vos P, Kooistra M. Daily hemodialysis in the Netherlands. 5th International Symposium on Home Hemodialysis. 1999, February28 -March 2, Charlotte, NC.
31. Kjellstrand CM, Blagg CR, Twardowski ZJ, Bower J. Blood access and daily hemodialysis: clinical experience and review of the literature. Asaio J 2003;49:645-9.
32. Agar JWM, Somerville CA, Dwyer KM, Simmonds RE, Boddington JM, Waldron CM. Nocturnal hemodialysis in Australia. Hemodial Int 2003;7:278-89.
33. Pipkin M, Craft V, Spencer M, Lockridge Jr RS. Six years of experience with nightly home hemodialysis access. Hemodial Int 2004;8:349-53.
34. Vos PF, Zilch O, Kooistra MP. Clinical outcome of daily dialysis. Am J Kidney Dis 2001;37:S99-S102.
35. Peterson P. Fistula cannulation: the buttonhole technique. Nephrol Nurs J 2002;29:195.
36. Twardowski ZJ. Constant site (Buttonhole) method of needle insertion for hemodialysis. Dial Transplant 1995;24:559-76.
37. Windus DW, Jendrisak MD, Delmez JA. Prosthetic fistula survival and complications in hemodialysis patients: effects of diabetes and age. Am J Kidney Dis 1992;19:448-52.
38. Goldwasser P, Michel MA, Collier J, Mittman N, Fein PA, Gusik SA et al. Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival. Am J Kidney Dis 1993;22:215-25.
39. Fagugli RM, Reboldi G, Quintaliani G, Pasini P, Ciao G, Cicconi B et al. Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 2001;38:371-6.
40. Lai KN, Yin JA, Yuen PM, Li PK. Effect of hemodialysis on protein C, protein S, and antithrombin III levels. Am J Kidney Dis 1991;17:38-42.
41. Friedman AN, Bostom AG, Levey AS, Rosenberg IH, Selhub J, Pierratos A. Plasma total homocysteine levels among patients undergoing nocturnal versus standard hemodialysis. J Am Soc Nephrol 2002;13:265-8.
42. Pisoni RL. Vascular access use and outcomes: results from the DOPPS. Contrib Nephrol 2002;(13):13-9.
43. Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 2002;61:305-16.
44. NKF-DOQI clinical practice guidelines for vascular access. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 1997;30:S150-91.
45. Taylor G, Gravel D, Johnston L, Embil J, Holton D, Paton S. Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol 2002;23: 716-20.
46. Kronung G. Plastic Deformation of Cimino fistula by repeated puncture. Dial Transplant 1984;13:635-8.
47. Scribner BH. The overriding importance of vascular access. Dial Transplant 1982;13:625.
48. Twardowski ZJ, Kubara H. Different sites versus constant sites of needle insertion into arteriovenous fistulas for treatment by repeated dialysis. Dial Transplant 1979;8:978-80.